osseinum hydroxyapatite compound

Poland

Drugs containing this active substance

  • OSTEOGENON

    The medicine is used in the treatment of osteoporosis (in elderly people, post-menopausal women, or after steroid use), in regulating calcium and phosphorus levels during pregnancy and breastfeeding, and as an adjunct therapy after bone fractures.

    Form: tablets, film-coated

    Active substance Dosage
    osseinum hydroxyapatite compound 830 mg

    ATC: M05BX

    Manufacturer: Progipharm Pierre Fabre Medicament